Location
Boston, MA
Holdings as of
9/30/2022
Date filed
11/14/2022
Form type
13F-HR
Num holdings
114
Total value ($000)
$1,941,092
Net value change ($000)
-280,051 (-12.6%)
New positions
19
Sold out positions
21
Turnover %
52.3%
Sector allocation + QoQ delta (equities-only)
Prev filing: 8/15/2022 Next filing: 2/14/2023 SEC filing

Snapshot: Change Analysis

Compared to Q2 2022
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
TSLA 55,294 199.1%
ON 33,325 NEW
TMDX 32,839 1953.5%
FSLR 30,911 NEW
SHLS 24,938 189.2%
ENVX 24,254 84.9%
ENPH 23,595 40.8%
RIVN 21,718 NEW
PAYC 21,151 755.1%
BILL 18,365 NEW
Top Reduces (Value $000, Stocks/ETFs)
Horizon Therapeutics Public Ltd Co -69,695 -100.0%
SITM -67,777 -100.0%
SIMO -52,748 -100.0%
MPWR -48,611 -73.4%
CRM -39,262 -100.0%
ABNB -21,429 -100.0%
CRWD -20,449 -26.7%
CHWY -19,750 -100.0%
FRPT -19,283 -100.0%
AMD -18,734 -100.0%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 733,483 (37.8% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type